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ABSTRACT 
Glycans are macromolecules that contain several classes. Glycans can play an important 
role in biological activities. Studying the cell surface glycans can provide a very powerful way to 
understand the fundamental process. Also it could help to regulate expected cell response. Thus 
it is very necessary to have a method to detect cell- surface glycans efficiently.  
An efficient method for glycan detection is necessary. Metabolic glycan labeling and 
chemoenzymatic glycan labeling are most commonly used. Chemoenzymatic glycan labeling is a 
rapid and sensitive method which also has high specificity. This method can be applied in both 
vitro and vivo. However the availability of unnatural sugar nucleotides functioned by 
bioorthogonal groups is the main limitation for chemoenzymatic labeling.  
In this thesis, UDP-GlcNAc and UDP-GalNAc derivatives were prepared for further 
chemoenzymatic labeling by using chemoenzymatic synthesis method. 
INDEX WORDS: Chemoenzymatic Glycan Labeling, Metabolic Labeling, Sugar Nucleotide, 
Bioorthogonal Chemistry, Click Chemistry  
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1 INTRODUCTION 
Glycans are macromolecules that made up of ten monosaccharides: glucose (Glc), sialic 
acid (Sia), galactose (Gal), mannose (Man), N-acetylglucosamine (GlcNAc), N-
acetylgalactosamine (GalNAc), fucose (Fuc)andxylose (Xyl).1Glycans mainly have three 
categories: O-linked glycans, N-linked glycans and glycolipids.2 
It is well-known that glycans play important roles in many fields, such as cell-cell 
interaction, cell-pathogen interactions, immunity, stability of proteins and cancer.3-5 For 
example, glycans can be used to detect blood types, because blood types are based on the glycan 
structures.6 
Studying the cell surface glycans can provide a very powerful way to understand the 
fundamental process. Also it could help to regulate expected cell response. Thus it is very 
necessary to have a method to detect cell- surface glycans efficiently. 
In previous studies, glycans detection was using lectins and antibodies.7 Lectins and 
antibodies can be used in the glycan detection mainly because of the specificities they have.8At 
the same time, lectins and antibodies binding glycans has high affinity, which is also benefit the 
detection among variety of cell surface glycans.9 
But this method was suffered from several reported disadvantages, such as the antibodies 
which are using for binding glycans, especially IgM isotype are difficult to raise, besides the 
binding affinity is always very low.10 At the same time, most lectins do not have strong 
specificity.11 Those two main drawbacks make the study of the glycans much more difficult.12 
Later on, chemical methods became popular for the detection of glycans.13 It has been 
used for a long time. However chemical methods cannot be sued widely because the toxicity of 
chemicals.12 For instance, in order to detect sialic acid, researchers often use alcian blue and 
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periodic acid, which are all damaging the carbohydrate chains.14 Thusthis method cannot be used 
for furthermore applications.  
Metabolic labeling was then came up, this is a powerful tool for the detection of 
glycans.15 In order to achieve the goal of glycoprotein enrichment, using metabolic labeling 
combined with biorthogonal method has many advantages.16 Compared with antibodies or lectins 
poor specificities and weak substrate binding, the chemical reporter will directly bind with 
glycan, glycosylation-specific enrichment will be achieved by using specific probes.11 However 
metabolic labeling suffered low efficiency,17 toxicity for cellular system, and limitations in 
human sample’s glycoprotein enrichment.18-19 
There are some popular detection methods were then reported. Such as detection of 
fucosylated,20-21 sialylated22 and mucin-type O-glycans23 in living cells by using metabolic 
labeling.12 However metabolic labeling is not available for detection of disaccharides or 
trisaccharides, because those higher order glycans contains monosaccharides, some precursors 
could enter varieties of glycan biosynthetic pathways which has many glycosyltransferases are 
involved, so the specificity of the linkage is difficult to be controlled.12, 19Besides there are not 
enough research could prove that metabolic labeling could be used in human, so rather than 
metabolic labeling, a good detection method still need to be developed.  
In order to solve those limitations of chemical methods detection and metabolic labeling 
methods, a new method called chemoenzymatic labeling was came up.24 Chemoenzymatic 
glycan labeling is a technique that using glycosyltransferases and unnatural sugar nucleotide 
linked together, at the same time, take advantage of bioorthogonal chemical tags in order to 
achieve specific glycan labeling in biological samples.25 According to the strategy, 
chemoenzymatic labeling method is able to detect glycans both on the cell surface and in cell 
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lysates.26 As I mentioned previously, chemical methods and metabolic labeling cannot label 
higher orders of glycans, while chemoenzymatic labeling can solve this limitation perfectly 
because of the high specificity of glycosyltransferases.12 
The first chemoenzymatic glycan labeling method was reported by Hsieh-Wilson’s group 
in 2004.24 Their idea was using a mutant galactosylransferase (Y289L GalT) to transfer a ketone 
onto an O-GlcNAc modified protein.24 After transferred, biotin was attached on the ketone, and 
then using streptavidin (HRP) for the detection of the O-GlcNAc glycosylated protein.24 This 
method is more efficient and specific to detect the O-GlcNAc modified protein compared to 
traditional methods.12 
Bertozzi and co-workers came up with a glycan imaging technology only using small 
molecule by two-step reaction.27 First, an unnatural glycan with chemical group metabolically 
into target sugar chain. Second, a covalent reaction occurred between chemical group and 
imaging probe, in order to be detected.28 
The study of the glycosylation has many challenges; the biggest one is because of the 
difficulties of synthesis of unnatural glycan and the complexity of glycansstructures.29 The 
existing methods have many limitations which including the low affinity, while chemoenzymatic 
labeling is a new method could solve those limitations.12 
In the past decades, bioorthogonal reactions has a big impact in chemical biology, also 
has many applications on the detection of cell surface glycans.28, 30 Bioorthogonal reaction can be 
widely used because the size of the bioorthogonal probes is not big, those probes will not change 
glycan structure, and will not do harm to the living cells or disturb their native environment.12, 
27Because there are so many claims to the reaction conditions, therefor in the past decades, only 
few biorthogonal reactions were well developed, including Staudinger ligation,31 copper-
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catalyzed azide-alkyne cycloaddition (also known as CuAAC),32 strain-promoted alkyne-azide 
cycloadditions ( also known as Cu-free click chemistry or SPAAC).33 Those reactions have been 
widely used for labeling glycans in living cells or cell lysates.28 
 
Figure 1.1Staudinger Ligation 
 
Staudinger ligation was the first bioorthogonal reaction reported by Staudinger and co-
worker in 1919.31 This is a photo-type bioorthogonal ligation reaction that transform azides into 
primary amines by phosphines.34 This reaction was used to target biomolecules not only in living 
cells but also living animals.26 Later on, some other improvements were made for this reaction, 
such as use modified reagent. Accompany with those advantages, Staudinger ligation suffered 
from the slow kinetics and the phosphine reagents are easy oxidized during the reaction progress, 
thus this reaction is not a perfect candidate for the glycan detection.12 
 
Figure 1.2Copper-Catalyzed Click Chemistry 
 
To date until now, the most popular and common bioorthogonal method is copper-
catalyzed click chemistry.27, 32 This is a copper-catalyzed cycloaddion reaction between alkyne 
and azide to form a 5 membered ring.35 In early 2000s, Sharpless group and Meldal group 
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discovered nearly at the same time that this reaction could be accelerate by copper dramatically, 
and this reaction can be occurred in aqueous system.12, 31Although this copper-catalyzed click 
reaction has been widely used in chemical biology, however, copper is a toxic reagent which will 
do harm to living cells or the biological system, so this method has limitations in many 
applications.12, 36And the toxicity of Cu(I) makes this method not good enough to be further used 
in many area, such as diagnosis in human diseases.12 In order to solve this problem, some 
researchers tried to decrease the amount of Cu (I) usage to decrease the damage to the living 
cells.12, 33 
 
Figure 1.3 Strain-Promoted Azide-Alkyne Cycloaddition 
 
After limited success, a safer method is still needed without devastating living cells. 
Bertozzi and co-worker further developed a copper free click chemistry which also named 
Strain-promoted azide-alkyne cycloaddiion (SPAAC).33 Instead of linear alkyne, they used 
strained cyclooctynes. Without using toxic Cu(I), this form of alkyne can react with azide 
quickly and highly reactively in biological system.37 This method do no harm to living cells and 
living animals, thus it has been widely used and remain the most popular and common click 
reaction. Because of its advantages, it also served as standard method of chemoenzymatic glycan 
labeling.12 
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1.1 Purpose of the Study 
Glycans on cell surface always play an important role in many area, such as cell death, 
cell migration, and immune response etc. Finding efficient methods for the detection of glycans 
on cell surface is a major problem that researchers are facing. Although chemoenzymatic 
labeling of specific glycans is a good method to address this problem, but lack of those related 
sugar nucleotides or sugar nucleotide derivatives is the impediment to research’s progress. So it 
is extremely important for us to synthesis those sugar nucleotide derivatives. 
There are some common monosaccharides in mammalian cells: glucose (Glc), sialic acid 
(Sia), galactose (Gal), mannose (Man), N-acetylglucosamine (GlcNAc), N-acetylgalactosamine 
(GalNAc), fucose (Fuc) and xylose (Xyl). 
GlcNAc
Fuc Neu5Ac
Neu5Gc
XylGlc
Man
Gal
GalNAc
 
Figure 1.4 Symbolic Representations of Common Monosaccharides in Mammalian Cells 
 
GlcNAc and GalNAc are commonly existing in both bacteria and mammalian cells. They 
are C-4 anomers which has very important significance in structure and functionality. GlcNAc is 
structural units in backbone of bacteria’s cell walls. GlcNAc is an important component of 
glycosaminoglycan (GAG) and hyaluronic acid (HA). GlcNAc take part in many biological 
pathways, the most identical pathway is regulating signal transduction pathway by glycosylation 
of O-GlcNAc protein. GalNAc is a component of two glycosaminoglycans: chondroitin sulfuric 
acid and dermatan sulfate. It is also the first glycosyl of mucin type glycosylation. 
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Isolation and purification of defined sugar nucleotides from nature is very difficult, thus it 
is necessary to synthesize sugar nucleotides and their derivatives. In the past decades, researchers 
already gained a great progress related to the both chemical and enzymatic synthesis of sugar 
nucleotides. Compared with enzymatic synthesis, chemical synthesis suffered from several 
protection and de-protection steps.  
The most common enzyme used in chemoenzymatic synthesis is glycosyltransferases. It 
is an efficient enzyme that could specific sugar moiety from a door to an acceptor. The 
advantage of using glycosyltransferases is the high specificity and high efficiency.  
 
Figure 1.5 Synthesis Pathway of Sugar Nucleotide 
 
Sugar nucleotide also named nucleotide sugar, there are 9 most common sugar in 
mammalian cells: UDP-Glu, UDP-Gal, UDP-GlcNAc, UDP-GalNAc, UDP-Xyl, UDP-GlcA, 
GDP-Man, GDP-Fuc and CMP-Sialic acid (Figure 1). Sugar nucleotides and their derivatives in 
very important due to its role in research of glycoconjugate biosynthesis pathway. Thus, 
synthesis of natural and unnatural sugar nucleotides is very significant in the field of 
biochemistry and pharmaceutical chemistry. 
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2 EXPERIMENT 
Chemical synthesis of UDP-GlcNAc and UDP-GalNAc derivatives is a reaction contains 
multiple steps and purification steps which suffered from low yield and tedious process. On the 
contrary, glycoslytransferases can achieve an efficient biosynthesis pathway. Especially, one pot 
multienzyme system provide a very efficient approach for the production of UDP-GlcNAc and 
UDP-GalNAc derivatives. 
2.1 Expression and purification of NahK, GlumU, AGX1 
As reported, N-acetylhexisamin kinase (NahK) is an efficient transferase which was 
found in Bifidobacterium longum. GalNAc/GlcNAc derivatives act as substrate could react with 
ATP phosphate donor and then synthesis GlcNAc-1-P/ GalNAc-1-P by using this enzyme 
efficiently. AGX1 is an uridylyltransferase from human which was reported has a good activity 
to synthesis UDP-GalNAc/ UDP-GalNAz from GalNAc-1-P/ GlcNAc-1-P.  
For protein production, adding NahK enzyme strain and 50µg/mL Kanamycin into 6ml 
LB medium, incubated at 37 °C for overnight. Transfer culture into 2L LB medium with 
Kanamycin, and culture for about 10 h. Adding isopropyl β-D-1-thiogalactopyranoside (IPTG) to 
the expression medium, then culture at 16 °C overnight. After expression, the cells were 
collected by centrifuge at 4,000 rpm for 30 mins. Discard supernatant, use 35mL lysis buffer to 
re-suspended pellet. Cell was fully lysed by sonication in ice-water bath. Then centrifuge 
suspension by centrifuge at 13,500 rpm at 4°C for 30 mins. Discard pellet, collect the 
supernatant. 
The supernatant was immediately loaded in to a column which contains Ni2+affinity 
beads twice. Washing the column by wash buffer, and then use a higher imidazole gradient 
elution buffer to elute the protein. 
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2.2 Enzymatic synthesis of UDP-GlcNAc derivatives 
With the GlcNAc derivatives ready for use, I performed one-pot multienzymatic reaction 
to synthesis UDP-GlcNAc derivatives by using NahK, AGX1 or GlumU and PPA.  
 
Figure 2.1 Synthesis Pathway of UDP-GlcNAc Derivatives 
 
This is an effective route which put substrate and all enzymes mix together for UDP-
GlcNAc derivatives. Table below shows the reaction system. 
Table 2.1Small Reaction System for UDP-GlcNAc synthesis 
50ul Reaction system  
 
GlcNAc derivatives 20mM 
ATP 20mM 
UTP 20mM 
Tris-Hcl 20mM 
Mg2+ 10mM 
H2O 
 
Adjust Ph (1M NaOH) 
 
NahK&AGX1(or GlmU)&PPA 3ul 
 
After overnight reaction, UDP-GlcNAc derivative was formed. Then P-2 column was 
used for purification. 
2.3 Enzymatic synthesis of UDP-GalNAc derivatives 
With the GalNAc derivatives ready for use, we performed one-pot multienzymatic 
reaction to synthesis UDP-GalNAc derivatives. I tried both NahK and GlmU to find out the most 
efficient one, and further did large scale reactions. 
10 
 
 
Figure 2.2 Synthesis Pathway of UDP-GalNAc Derivatives 
 
This is an effective route which put substrate and all enzymes mix together for UDP-
GalNAc derivatives. This method takes less time than the chemical synthesis of UDP-GalNAc 
derivatives, which can be widely use for the synthesis of unnatural sugar nucleotides derivatives.  
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3 RESULTS 
The synthesized UDP-GalNAc/UDP-GlcNAc and their derivatives are all confirmed by NMR. 
Overall, I synthesized 10 UDP-GlcNAc derivatives and 7 GalNAc derivatives in total which are 
ready for future chemoenzymatic labeling. 
3.1 Enzyme activity study of NahKand AGX1 
The enzyme activity of NahK and AGX1 was determined by four small scale reactions. 
All four reaction systems were performed in a 50 ul reaction system mixture, each of the mixture 
containing 10mM substrate, 15mM ATP, 15mM UTP, 1.5mM Mg2+, 2.5mM Tris-HCL buffer 
(pH 8.0). Adjust pH to around 8.0. Adding water to the first reaction system up to 50ul. Adding 
1ug NahK and water into the second reaction system up to 50ul. Adding 1ug AGX1 and water 
into the third reaction system up to 50ul. Adding 1ug NahK, 1ug AGX1 and water to the fourth 
reaction system. 
Thus from TLC analysis, we can observe that the starting materials was mostly consumed 
in 12h, and a spot of the product UDP-GalNAc and byproduct ADP, UDP was showed clearly. 
(GlcNAc/GalNAc has no fluorescence under the short wavelength UV light, meanwhile sugar 
nucleotides has fluorescence spot under the UV light). 
3.2 Chemoenzymatic synthesis of UDP-GlcNAc derivatives 
In order to synthesis UDP-GlcNAc derivatives, highly efficient one pot multienzyme 
method was used.  
This reaction is a 15ml reaction system, contains 10mM GlcNAc or its derivatives, 
15mM UTP, 15 Mm ATP, 10mM Mg2+, 5mM Tris-HCL, using NaOH adjust pH to 8.0, then add 
1mL NahK and 1mL AGX1. The reaction progress was determined by Thin-layer 
Chromatography (EtOAc: MeOH: H2O: HOAC=5:2:1.4:0.4). 
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Table 3.1 Compound Design and reaction yield of UDP-GlcNAc Derivatives 
 
After overnight reaction at 37°C, and the reaction fully finished (determined by TLC), 
using NaOH to adjust pH to 9.0, adding 120U of Alkaline phosphatase to hydrolyze by-products 
UDP and UDP, and the remaining ATP and UTP at 37°C for overnight. Once all those 
byproducts were hydrolyzed, equal amount of Ethonal was added to precipitate all the remaining 
enzymes. The mixture was centrifuged at 6000 rpm for 20 mins, the supernatant were collected 
and concentrated to 5ml. The concentrated samples were loaded into P2 column for purification. 
The fractions that contains UV-visible spots are pure product we need. The fractions contains 
product were collected and concentrated by oil pump. The concentrated product was formed to 
white powder by lyophilization. 
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Table 3.2 Compound Design and reaction yield of UDP-GlcNAc Derivatives 
 
In summary, there are 10 UDP-GlcNAc derivatives were synthesized successfully, all the 
products were thenconfirmed by NMR spectrum. 
3.2.1 1H-NMR and 13C-NMR analysis of compound 1 
1H NMR (400 MHz, D2O) δ 7.92 (d, J = 8.1 Hz, 1H), 6.01 – 5.90 (m, 2H), 5.51 (dd, J = 
7.2, 3.2 Hz, 1H), 4.36 – 4.30 (m, 2H), 4.25- 4.20 (m, 2H), 4.17 – 4.14 (m, 2H), 4.06 – 4.01 (m, 
2H), 3.91 – 3.86 (m, 1H), 3.83 – 3.76 (m, 3H), 3.54 (t, J = 9.6 Hz, 1H); 13C NMR (100 MHz, 
D2O) δ 170.90, 166.18, 151.72, 141.59, 102.56, 94.32, 94.26, 88.52, 83.08, 82.99, 73.71, 72.97, 
70.75, 69.54, 69.36, 64.92, 60.21, 53.66, 53.58, 51.50; 31P NMR (162 MHz, D2O) δ -11.28 (d, J 
= 17.2 Hz), -13.00 (d, J = 17.0 Hz). 
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Figure 3.1 The 1H-NMR of Compound 1 
 
Figure 3.2 The 13C-NMR of Compound 1 
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3.2.2 1H-NMR and 13C-NMR analysis of compound 2 
1H NMR (400 MHz, D2O) δ 5.21 (d, J = 3.3 Hz, 1H), 3.93 – 3.88 (m, 1H), 3.88 – 3.86 
(m, 1H), 3.79 – 3.72 (m, 2H), 3.60 (t, J = 6.3 Hz, 3H), 3.50- 3.44 (m, 2H), 2.61- 2.56 (m, 2H); 
13C NMR (100 MHz, D2O) δ 174.10, 166.23, 151.79, 141.66, 102.64, 94.55, 94.49, 88.56, 83.20, 
83.11, 73.79, 73.04, 70.92, 69.63, 69.52, 65.02, 64.96, 60.32, 53.66, 53.58, 47.08, 34.83; 31P 
NMR (162 MHz, D2O) δ -11.29 (d, J = 20.7 Hz), -13.05 (d, J = 20.7 Hz). 
 
Figure 3.3 The 1H-NMR of Compound 2 
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Figure 3.4 The 13C-NMR of Compound 2 
3.2.3 1H-NMR and 13C-NMR analysis of compound 3 
1H NMR (400 MHz, D2O) δ 7.98 (d, J = 8.1 Hz, 1H), 6.04 – 5.94 (m, 2H), 5.53 (dd, J = 
6.7, 2.8 Hz, 1H), 4.39 – 4.35 (m, 2H), 4.30 – 4.21 (m, 3H), 4.04 (d, J = 10.5 Hz, 1H), 3.95 (d, J = 
10.0 Hz, 1H), 3.90 – 3.74 (m, 3H), 3.57 (t, J = 9.6 Hz, 1H), 2.61 -2.58 (m, 2H), 2.52 (d, J = 7.7 
Hz, 2H), 2.39 (s, 1H); 13C NMR (100 MHz, D2O) δ 175.15, 166.22, 151.78, 141.65, 102.66, 
94.63, 94.57, 88.54, 83.65, 83.19, 83.10, 73.80, 73.01, 70.86, 70.04, 69.61, 69.52, 64.99, 64.94, 
60.30, 53.54, 34.27, 14.33; 31P NMR (162 MHz, D2O) δ -11.33 (d, J = 20.5 Hz), -13.13 (d, J = 
20.5 Hz). 
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Figure 3.5 The 1H-NMR of Compound 3 
 
Figure 3.6 The 13C-NMR of Compound 3 
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3.2.4 1H-NMR and 13C-NMR analysis of compound 4 
1H NMR (400 MHz, D2O) δ 7.93 (d, J = 8.1 Hz, 1H), 5.97 – 5.90 (m, 2H), 5.48 (dd, J = 
6.9, 3.0 Hz, 1H), 4.34- 4.30 (m, 2H), 4.25 – 4.13 (m, 2H), 3.97 (d, J = 10.5 Hz, 1H), 3.90 (d, J = 
9.8 Hz, 1H), 3.85- 3.74 (m, 3H), 3.52 (t, J = 9.6 Hz, 1H), 2.42 (t, J = 7.4 Hz, 1H), 2.33 (s, 1H), 
2.22 (t, J = 6.0 Hz, 1H), 1.81 – 1.74 (m, 2H); 13C NMR (100 MHz, D2O) δ 176.69, 166.17, 
151.71, 141.61, 102.58, 94.52, 94.46, 88.49, 84.83, 83.10, 83.01, 73.74, 72.94, 70.77, 69.75, 
69.53, 69.47, 64.87, 60.21, 53.51, 53.43, 34.54, 24.14, 17.14; 31P NMR (162 MHz, D2O) δ -
11.41 (d, J = 20.3 Hz), -13.13 (d, J = 20.3 Hz). 
 
Figure 3.7 The 1H-NMR of Compound 4 
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Figure 3.8 The 13C-NMR of Compound 4 
3.2.5 1H-NMR and 13C-NMR analysis of compound 5 
1H NMR (400 MHz, D2O) δ 7.96 (d, J = 8.1 Hz, 1H), 5.97 (m, 2H), 5.56 (dd, J = 6.9, 1.9 
Hz, 1H), 4.68 (s, 2H), 4.38- 4.34 (m, 2H), 4.28 – 4.18 (m, 3H), 3.92 – 3.84 (m, 2H), 3.81 – 3.74 
(m, 3H), 3.56 – 3.52 (m, 1H), 2.89 (s, 1H); 13C NMR (100 MHz, D2O) δ 166.24, 157.52, 151.80, 
141.60, 102.62, 94.88, 94.82, 88.37, 83.22, 83.13, 78.41, 75.68, 73.81, 72.94, 71.29, 69.61, 
69.37, 64.90, 64.84, 60.25, 55.51, 55.42, 52.94; 31P NMR (162 MHz, D2O) δ -11.34 (d, J = 20.7 
Hz), -13.09 (d, J = 20.7 Hz). 
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Figure 3.9 The 1H-NMR of Compound 5 
 
Figure 3.10 The 13C-NMR of Compound 5 
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3.2.6 1H-NMR and 13C-NMR analysis of compound 6 
1H NMR (400 MHz, D2O) δ 7.94 (d, J = 8.1 Hz, 1H), 5.95 – 5.93 (m, 2H), 5.49 (dd, J = 
7.0, 3.2 Hz, 1H), 4.35 – 4.32 (m, 2H), 4.26 – 4.24 (m, 1H), 4.21 – 4.16 (m, 4H), 4.02- 3.98 (m, 
1H), 3.92– 3.88 (m, 1H), 3.86– 3.76 (m, 5H), 3.53 (t, J = 9.6 Hz, 1H), 2.85 (t, J = 2.3 Hz, 1H), 
2.64 (t, J = 6.1 Hz, 2H); 13C NMR (100 MHz, D2O) δ 174.19, 166.22, 151.76, 141.58, 102.59, 
94.52, 94.46, 88.43, 83.15, 83.10, 83.05, 79.22, 75.84, 73.75, 72.94, 70.86, 69.54, 69.46, 69.40, 
65.67, 64.88, 64.86, 60.23, 57.73, 53.61, 53.52, 35.55; 31P NMR (162 MHz, D2O) δ -11.41 (d, J 
= 20.8 Hz), -13.15 (d, J = 20.8 Hz). 
 
Figure 3.11 The 1H-NMR of Compound 6 
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Figure 3.12 The 13C-NMR of Compound 6 
3.2.7 1H-NMR and 13C-NMR analysis of compound 7 
1H NMR (400 MHz, D2O) δ 7.95 (d, J = 8.1 Hz, 1H), 5.97 – 5.91 (m, 2H), 5.92 – 5.81 
(m, 1H), 5.49 (dd, J = 6.6, 2.7 Hz, 1H), 5.06 (dd, J = 26.7, 13.8 Hz, 2H), 4.37- 4.35 (m, 2H), 4.27 
– 4.19 (m, 3H), 3.95 (dd, J = 23.7, 10.0 Hz, 1H), 3.88 -3.77 (m, 3H), 3.54 (t, J = 9.6 Hz, 1H), 
2.45- 2.42 (m, 2H), 2.37 – 2.33 (m, 2H); 13C NMR (100 MHz, D2O) δ 176.78, 166.20, 151.75, 
141.64, 137.14, 115.45, 102.62, 94.64, 94.58, 88.49, 83.19, 83.10, 73.76, 72.97, 70.78, 69.58, 
69.53, 64.94, 60.27, 53.54, 53.45, 34.84, 29.25; 31P NMR (162 MHz, D2O) δ -11.43 (d, J = 20.6 
Hz), -13.22 (d, J = 20.5 Hz). 
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Figure 3.13 The 1H-NMR of Compound 7 
 
Figure 3.14 The 13C-NMR of Compound 7 
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3.2.8 1H-NMR and 13C-NMR analysis of compound 8 
1H NMR (400 MHz, D2O) δ 7.96 (d, J = 8.4 Hz, 1H), 5.98- 5.96 (m, 2H), 5.60 – 5.37 (m, 
1H), 4.39 – 4.35 (m, 2H), 4.29- 4.18 (m, 3H), 4.00 (d, J = 10.4 Hz, 1H), 3.94 (d, J = 9.1 Hz, 1H), 
3.85 (m, 3H),  3.56 (t, J = 9.6 Hz, 1H), 2.87 (dd, J = 12.6, 6.4 Hz, 2H), 2.62 (t, J = 6.7 Hz, 2H), 
2.24 (s, 3H); 13C NMR (100 MHz, D2O) δ 214.03, 175.68, 166.18, 151.75, 141.64, 102.60, 
94.58, 94.52, 88.55, 83.17, 83.07, 73.78, 73.01, 70.92, 69.60, 69.48, 65.00, 64.95, 60.31, 53.64, 
53.55, 38.20, 29.36, 29.17; 31P NMR (162 MHz, D2O) δ -11.33 (d, J = 18.4 Hz), -13.04 (d, J = 
19.0 Hz). 
 
Figure 3.15 The 1H-NMR of Compound 8 
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Figure 3.16 The 13C-NMR of Compound 8 
3.2.9 1H-NMR and 13C-NMR analysis of compound 9 
1H NMR (400 MHz, D2O) δ 7.96 (d, J = 8.0 Hz, 1H), 5.98- 5.96 (m, 2H), 5.53 (d, J = 4.0 
Hz, 1H), 4.38- 4.36 (m, 2H), 4.28 – 4.20 (m, 3H), 4.05 (jd, J = 10.3 Hz, 1H), 3.93 (d, J = 9.8 Hz, 
1H), 3.83 (m, 3H), 3.56 (t, J = 9.5 Hz, 1H), 2.81- 2.75 (m, 4H); 13C NMR (100 MHz, D2O) δ 
173.14, 166.22, 151.77, 141.62, 102.62, 94.57, 94.46, 88.53, 83.06, 73.75, 73.02, 70.90, 69.58, 
69.53, 69.46, 64.95, 60.29, 59.31, 53.57, 30.44, 12.69; 31P NMR (162 MHz, D2O) δ -11.37 (d, J 
= 17.7 Hz), -13.06 (d, J = 17.5 Hz). 
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Figure 3.17 The 1H-NMR of Compound 9 
 
Figure 3.18 The 13C-NMR of Compound 9 
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3.2.10 1H-NMR and 13C-NMR analysis of compound 10 
1H NMR (400 MHz, D2O) δ 7.98 (d, J = 7.9 Hz, 1H), 6.00 (s, 2H), 5.53 (s, 1H), 4.38 (s, 
2H), 4.29 – 4.21 (m, 3H), 4.02 (d, J = 10.2 Hz, 1H), 3.94 (d, J = 10.0 Hz, 1H), 3.85 (m, 3H), 3.56 
(t, J = 9.4 Hz, 1H), 2.30 (d, J = 6.4 Hz, 2H), 1.69 (t, J = 7.0 Hz, 2H), 1.04 (s, 3H); 13C NMR (100 
MHz, D2O) δ 175.91, 166.22, 151.79, 141.70, 102.64, 99.82, 94.58, 94.39, 88.54, 83.18, 83.06, 
73.78, 70.90, 69.61, 69.58, 69.54, 64.95, 60.30, 53.73, 30.11, 29.81, 26.28, 18.51; 31P NMR (162 
MHz, D2O) δ -11.48 (d, J = 18.6 Hz), -13.24 (d, J = 17.7 Hz). 
 
 
Figure 3.19 The 1H-NMR of Compound 10 
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Figure 3.20The 13C-NMR of Compound 10 
 
3.3 Chemoenzymatic synthesis of UDP-GalNAc derivatives 
This reaction is a 15ml reaction system, contains 10mM GalNAc or its derivatives, 
15mM UTP, 15 Mm ATP, 10mM Mg2+, 5mM Tris-HCL, using NaOH adjust pH to 8.0, then add 
1mL NahK and 1mL AGX1. The reaction progress was determined by Thin-layer 
Chromatography (EtOAc:MeOH:H2O:HOAC=5:2:1.4:0.4). 
After overnight reaction at 37°C, and the reaction fully finished (determined by TLC), 
using NaOH to adjust pH to 9.0, adding 120U of Alkaline phosphatase to hydrolyze by-products 
UDP and UDP, and the remaining ATP and UTP at 37°C for overnight.Once all those 
byproducts were hydrolyzed, equal amount of Ethonal was added to precipitate all the remaining 
enzymes. The mixture was centrifuged at 6000 rpm for 20 mins, the supernatant were collected 
and concentrated to 5ml. 
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Table 3.3 Compound Design and reaction yield of UDP-GalNAc Derivatives 
 
The concentrated samples were loaded into P2 column for purification. The fractions that 
contains UV-visible spots are pure product we need. The fractions contains product were 
collected and concentrated by oil pump. The concentrated product was formed to white powder 
by lyophilization. 
Table 3.4 Compound Design and reaction yield of UDP-GalNAc Derivatives 
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Compound 11-15 were successfully synthesized by NahK and AGX1, but there has no 
activity through entry b6 to b11. Compound 16 and compound 17 were synthesized by another 
synthesis pathway which is shown in Figure 3.21. 
 
Figure 3.21 Strategy for Synthesis of Compound 16 and Compound 17 
 
In summary, 7 UDP-GalNAc derivatives were synthesized successfully, and all the 
products werethen confirmed by NMR spectrum. 
3.3.1 1H-NMR and 13C-NMR analysis of compound 11 
1H NMR (400 MHz, D2O) δ 7.96 (d, J = 8.1 Hz, 1H), 5.98- 5.96 (m, 2H), 5.56 (dd, J = 
6.8, 3.1 Hz, 1H), 4.38- 4.34 (m, 2H), 4.31- 4.28 (m, 2H), 4.23- 4.18(m, 3H), 4.04 (s, 1H), 3.97 
(dd, J = 11.0, 2.8 Hz, 1H), 3.81 – 3.73 (m, 3H), 3.61 (t, J = 6.4 Hz, 2H), 2.77 – 2.59 (m, 2H); 13C 
NMR (100 MHz, D2O) δ 174.30, 166.21, 151.78, 141.65, 102.60, 94.68, 88.48, 83.22, 83.13, 
73.75, 72.06, 69.62, 68.40, 67.62, 65.00, 61.01, 59.36, 49.78, 49.73, 47.06, 34.84; 31P NMR (162 
MHz, D2O) δ -11.33 (d, J = 21.1 Hz), -13.00 (d, J = 21.0 Hz). 
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Figure 3.22 The 1H-NMR of Compound 11 
 
Figure 3.23 The 13C-NMR of Compound 11 
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3.3.2 1H-NMR and 13C-NMR analysis of compound 12 
1H NMR (400 MHz, D2O) δ 7.95 (d, J = 8.1 Hz, 1H), 5.97 – 5.95 (m, 2H), 5.53 (dd, J = 
6.8, 3.3 Hz, 1H), 4.37 – 4.33 (m, 2H), 4.29 – 4.26 (m, 2H), 4.22- 4.17 (dd, J = 12.6, 7.0 Hz, 2H), 
4.03 (d, J = 2.4 Hz, 1H), 3.96 (dd, J = 11.0, 2.9 Hz, 1H), 3.79 – 3.70 (m, 2H), 2.57 (dd, J = 13.4, 
6.1 Hz, 1H), 2.50 -2.47 (m, 2H), 2.35- 2.34 (m, 1H); 13C NMR (100 MHz, D2O) δ 175.36, 
166.20, 151.76, 141.64, 102.61, 94.79, 88.47, 83.61, 83.20, 83.11, 73.76, 72.02, 69.95, 69.59, 
68.38, 67.56, 64.98, 64.95, 60.98, 49.69, 49.67, 34.28, 14.30; 31P NMR (162 MHz, D2O) δ -
11.37 (d, J = 20.7 Hz), -13.08 (d, J = 20.9 Hz). 
 
Figure 3.24 The 1H-NMR of Compound 12 
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Figure 3.25 The 13C-NMR of Compound 12 
3.3.3 1H-NMR and 13C-NMR analysis of compound 13 
1H NMR (400 MHz, D2O) δ 7.97 (d, J = 8.0 Hz, 1H), 5.98- 5.95 (m, 2H), 5.59 (dd, J = 
6.5, 2.6 Hz, 1H), 4.68 (s, 2H), 4.37 – 4.34 (m, 2H), 4.268- 4.23 (m, 2H), 4.19 – 4.16 (m, 2H), 
4.04 (s, 1H), 3.95 (dd, J = 29.0, 10.7 Hz, 2H), 3.82 – 3.69 (m, 2H); 13C NMR (100 MHz, D2O) δ 
166.20, 157.69, 151.78, 141.64, 102.64, 95.02, 88.40, 83.26, 83.17, 78.47, 75.71, 73.82, 72.04, 
69.65, 68.38, 67.85, 64.88, 61.00, 52.96, 51.58; 31P NMR (162 MHz, D2O) δ -11.32 (d, J = 20.7 
Hz), -12.96 (d, J = 20.7 Hz). 
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Figure 3.26 The 1H-NMR of Compound 13 
 
Figure 3.27 The 13C-NMR of Compound 13 
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3.3.4 1H-NMR and 13C-NMR analysis of compound 14 
1H NMR (400 MHz, D2O) δ 7.96 (d, J = 8.1 Hz, 1H), 6.00 – 5.90 (m, 3H), 5.59 (dd, J = 
6.9, 3.2 Hz, 1H), 5.34 (dd, J = 17.3, 1.5 Hz, 1H), 5.24 (dd, J = 10.6, 1.3 Hz, 1H), 4.58 -4.56 (m, 
2H), 4.37 – 4.33 (m, 2H), 4.28 – 4.23 (m, 2H), 4.20 – 4.17 (m, 2H), 4.01 -3.97 (m, 1H), 3.98 (s, 
1H), 3.92 (dd, J = 10.9, 3.0 Hz, 1H), 3.77 – 3.72 (m, 2H); 13C NMR (100 MHz, D2O) δ 166.21, 
158.50, 151.78, 141.66, 132.70, 117.37, 102.63, 95.14, 95.08, 88.46, 83.24, 73.82, 72.03, 69.64, 
68.43, 67.86, 66.07, 64.93, 61.02, 51.52; 31P NMR (162 MHz, D2O) δ -11.27 (d, J = 19.8 Hz), -
12.84 (d, J = 19.8 Hz). 
 
Figure 3.28 The 1H-NMR of Compound 14 
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Figure 3.29 The 13C-NMR of Compound 14 
3.3.5 1H-NMR and 13C-NMR analysis of compound 15 
1H NMR (400 MHz, D2O) δ 7.91 (d, J = 8.0 Hz, 1H), 5.93- 5.91 (m, 2H), 5.51 (dd, J = 
6.9, 3.1 Hz, 1H), 4.34 – 4.29 (m, 2H), 4.27- 4.19(m, 3H), 4.17 – 4.13 (m, 2H), 3.99 (s, 1H), 3.92 
(dd, J = 10.9, 2.5 Hz, 1H), 3.76 – 3.68 (m, 2H), 2.78 – 2.67 (m, 4H); 13C NMR (100 MHz, D2O) 
δ 173.31, 166.20, 151.73, 141.58, 120.72, 102.54, 94.61, 88.47, 83.10, 83.01, 73.71, 72.05, 69.52, 
68.31, 67.49, 64.97, 64.92, 60.98, 49.74, 30.41, 12.64; 31P NMR (162 MHz, D2O) δ -11.34 (d, J 
= 21.0 Hz), -12.94 (d, J = 21.0 Hz). 
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Figure 3.30 The 1H-NMR of Compound 15 
 
Figure 3.31 The 13C-NMR of Compound 15 
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3.3.6 1H-NMR and 13C-NMR analysis of compound 16 
1H NMR (400 MHz, D2O) δ 7.96 (d, J = 8.1 Hz, 1H), 6.00 – 5.90 (m, 3H), 5.59 (dd, J = 
6.9, 3.2 Hz, 1H), 5.34 (dd, J = 17.3, 1.5 Hz, 1H), 5.24 (dd, J = 10.6, 1.3 Hz, 1H), 4.58 -4.56 (m, 
2H), 4.37 – 4.33 (m, 2H), 4.28 – 4.23 (m, 2H), 4.20 – 4.17 (m, 2H), 4.01 -3.97 (m, 1H), 3.98 (s, 
1H), 3.92 (dd, J = 10.9, 3.0 Hz, 1H), 3.77 – 3.72 (m, 2H); 13C NMR (100 MHz, D2O) δ 166.21, 
158.50, 151.78, 141.66, 132.70, 117.37, 102.63, 95.14, 95.08, 88.46, 83.24, 73.82, 72.03, 69.64, 
68.43, 67.86, 66.07, 64.93, 61.02, 51.52; 31P NMR (162 MHz, D2O) δ -11.27 (d, J = 19.8 Hz), -
12.84 (d, J = 19.8 Hz). 
 
Figure 3.32 The 1H-NMR of Compound 16 
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Figure 3.33The 13C-NMR of Compound 16 
3.3.7 1H-NMR and 13C-NMR analysis of compound 17 
1H NMR (400 MHz, D2O) δ 7.91 (d, J = 8.0 Hz, 1H), 5.93- 5.91 (m, 2H), 5.51 (dd, J = 
6.9, 3.1 Hz, 1H), 4.34 – 4.29 (m, 2H), 4.27- 4.19(m, 3H), 4.17 – 4.13 (m, 2H), 3.99 (s, 1H), 3.92 
(dd, J = 10.9, 2.5 Hz, 1H), 3.76 – 3.68 (m, 2H), 2.78 – 2.67 (m, 4H); 13C NMR (100 MHz, D2O) 
δ 173.31, 166.20, 151.73, 141.58, 120.72, 102.54, 94.61, 88.47, 83.10, 83.01, 73.71, 72.05, 69.52, 
68.31, 67.49, 64.97, 64.92, 60.98, 49.74, 30.41, 12.64; 31P NMR (162 MHz, D2O) δ -11.34 (d, J 
= 21.0 Hz), -12.94 (d, J = 21.0 Hz). 
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Figure 3.34 The 1H-NMR of Compound 17 
 
Figure 3.35The 13C-NMR of Compound 17 
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4 CONCLUSIONS 
In this study, I have successfully synthesized 17 UDP-GlcNAc derivatives and UDP-GalNAc 
derivatives in total by using chemoenzymatic synthesis method. Enzymes NahK, AGX1, GlmU 
and PpA were used. All the UDP-GlcNAc derivatives and UDP-GalNAc derivatives contains 
bioorthogonal groups. More significantly, those sugar nucleotides derivatives are potential new 
probes for further chemoenzymatic labeling of complex glycans. We anticipate this work will 
accelerate the development and application of chemoenzymatic labeling. 
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